A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
Clinical trial NCT04762407 · COMPLETED
Trial details
- NCT number
- NCT04762407
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2021-02-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.